Skip to content

NKSP clinical study

NKSP clinical study

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1080224057
Enrollment
40
Registered
2018-09-20
Start date
2018-09-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy person

Interventions

investigational material(s) Generic name etc : NKSP(food) INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material : once/day,3

Sponsors

Rohto pharmaceutical CO.,LTD
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) 35 to 44 years old(Smoker and non-smoker) (2) Non-somker subjects who need to have stopped smoking 3 months prior to the trial or (3) Smoker subjects who have to be smoking one box of paper cigarettes for an average day (4) BMI range: 18.5-25.0 kg/m2 (5) Drinking less than 20g of pure alcohol (2 unit equivalence) per average day (6) Subjects who can attend designated fixed period measurement schedule and take test items (7) Subjects who aren't using medications or supplememts which may influence the study 3 months prior to the trial (8) Subjects who understand the main points of the study and signs a consent form (9) Subjects who can provide semen for the evaluation

Exclusion criteria

Exclusion criteria: (1) Subjects having a fertility treatment (2) Subjects having treatment with Urologist or Obsterician (3) Subjects with infection and severe injury (4) Subjects who have had an operation within 6 months of starting the trial (5) Subjects who have allergies with the test items (6) Subjects with liver, renal and other dysfunction or medical history which may influence the reserch (7) Subjects who participate in other clinical and or laboratory tests 3 months prior of the the test or duration the trial (8) Subjects judged to be unsuitable as a subject as a result of the questionnaire (9) Subjects who are judged as inappropriate by the study personnel

Design outcomes

Primary

MeasureTime frame
other 8-OHdG

Secondary

MeasureTime frame
other Testosterone, creatine, spermine, zinc, sperm concentration, semen volume and total sperm number

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026